UiPath PATH Stock – The Automation Giant That the Market Has Quietly Given Up On

The way UiPath is currently positioned in the market is a little odd. Invoice processing, compliance checks, and data entry across a dozen different enterprise systems are just a few of the monotonous, soul-depleting tasks that everyday office life entails.

The company creates software to automate these tasks. By most accounts, as cost pressure increases and AI tools begin to penetrate workflows that were previously thought to be too complicated to handle, automation is precisely what businesses want more of in 2026. Nevertheless, PATH’s stock is currently trading close to the bottom of its 52-week range at $11.02, down about 30% since January, as if the business were quietly collapsing. It isn’t. This is why it’s important to pay attention to this.

UiPath reported Q4 fiscal 2026 revenue of $481 million, exceeding revenue expectations by 3.5% and earnings estimates by nearly 18%. This represents an increase of over 13% year over year. Over the past 12 months, free cash flow has been approximately $355.9 million. This is real money that the company is making, not a disappearing figure or a conjecture.

The stock’s intrinsic value, according to a discounted cash flow model applied to those numbers and analyst projections, is approximately $17.55 per share, suggesting that UiPath is trading at a 37% discount to the apparent value of the underlying business. These are not the cornerstones of a failing business. They resemble a business that has momentarily gone out of style.

When it comes to investing in technology, fashion is very important. It was a truly thrilling moment for UiPath. UiPath was founded by Daniel Dines, who transformed the company from a small Bucharest software shop into one of the more intriguing enterprise software stories of the 2010s. The company went public in 2021 at a valuation that seemed to price in a long period of dominance.

It was initially welcomed by growth-oriented funds and institutional investors. Among the more well-known supporters were Cathie Wood’s ARK funds. PATH then drifted and continued to drift as growth expectations subsided and the software industry as a whole re-rated lower. The early December 2025 52-week high of $19.84 already seems like a bygone era. The stock is currently closer to its 52-week low of $9.38 than it is to its peak.

It’s difficult to ignore a certain conflict between the company’s actual operations and how it is valued. At 20.6x, the P/E ratio is lower than both the peer group average of 24.5x and the software industry average of 29.4x. That implies, on paper, that investors are paying less for every dollar of UiPath’s profits than they would for a similar software brand. Some analysts see opportunity in that gap.

Others question whether the lower multiple actually represents a slower growth ceiling, more intense competition, or a product category that is more difficult to distinguish as AI features are integrated into rival platforms from Microsoft, Salesforce, and ServiceNow. Probably the most valid worry is the last one, so it’s worth considering.

Instead of opposing the AI encroachment narrative, UiPath has chosen to embrace it. The company is marketing itself as a platform for “agentic business orchestration”; founder Daniel Dines and chief product officer Raghu Malpani will discuss this concept in a live product webinar on April 6. The framing is intentional: rather than being the tool that AI agents replace, UiPath aims to be the layer that coordinates them across enterprise workflows.

Enterprise buyers who have already developed workflows on UiPath’s platform and are not interested in migrating might find the pitch appealing. Additionally, UiPath’s standalone case may be gradually undermined by larger platform vendors who incorporate automation features into products that customers already pay for. The competition is genuine and becoming more intense every quarter.

Some analysts believe that the current price already incorporates a significant amount of pessimism, perhaps more than the circumstances call for. The analyst target range ranges from about $12 on the cautious end to $17 on the optimistic end, with Simply Wall Street assigning a valuation score of five out of six.

Even the bears are not predicting a significant further decline because both figures are higher than where the stock is currently trading. It’s important to note that senior leadership isn’t cashing out in a panic either, even though the COO, CFO, and CAO recently received RSU grants, which is standard compensation practice.

As I watch UiPath get through this phase, it seems like a company that created something truly helpful and is now attempting to justify its continued relevance in a market that has already begun writing its obituary—possibly a bit too soon. The company is making money, exceeding projections, and getting ready to demonstrate its true potential with AI orchestration. It is another matter entirely if the market chooses to pay attention in April. However, the fundamentals appear to be holding their ground.